Sareum - Specialists in Structure-based Drug Discovery

Statement re. Bulletin Board speculation
05 June, 2009

Holding(s) in Company
24 April, 2009

Holding(s) in Company
20 April, 2009

Holding(s) in Company
23 March, 2009

Statement re Share Price Movement
23 March, 2009

News feed
requires RSS news reader

Sareum Holdings
Last Trading	0.28
Trade Time	15:50am
Change	-0.04
Open	0.32
Day's Range	0.28 - 0.28
Volume	200000

Sareum's small molecule drug discovery expertise is building value by developing oncology drug candidates for licencing to pharmaceutical and biotechnology companies

Providing protein structure-based research services to accelerate customers’ drug discovery programmes

Developing oncology drug candidates for licensing to pharmaceutical companies

Learn more about Sareum’s pre-clinical oncology pipeline of targeted small molecule drug candidates

Sareum Holdings Plc's house broker, Hybridan LLP, will from time to time publish research notes on the Company. You can download the research notes from this page.

Sareum's small molecule drug discovery expertise is building value by developing oncology drug candidates for licencing to pharmaceutical and biotechnology companies

Website last updated on: 9-June-2009